Global Clinical Trial Services Market

Report ID : 1071 | Published : 2021-07-23 | Pages: 140 | Format: PDF/EXCEL

The services used by biopharmaceutical or pharmaceutical companies to conduct clinical trial either for the approval of a new drug or biologic or for the entry of new generic or biosimilar to the market is known as clinical trial services. Increased research and development expenditure and entry of biosimilars to the market has boosted the growth of the clinical trial services market. Major companies have increased research and development expenditure to bring new molecules to the market in order to beat the market competition and to sustain the market position. A significant part of the research and development expenditure of pharmaceutical and biopharmaceutical companies goes on clinical trials, thus growing demand for new drug development and increase in a number of contract research organizations have boosted the growth of the global clinical trial services market. However, the stringent regulatory framework hampers the growth of the global clinical trials services market in the forecast period. Additionally, the lack of skilled professionals to conduct clinical trials also restrains the development of the global clinical trial services market.
The global clinical trials services market is segmented on the basis of clinical phase, therapy area, end-user, and geography. Based on the clinical phase, the global market is further sub-segmented into phase I, phase II, phase III, and others. On the basis of therapy area, the market is further segmented into oncology, neurological disorder, metabolic disease, cardiovascular, rare diseases, infectious diseases, and others. On the basis of therapy, are oncology segment is expected to hold the maximum share of the market due to the growing incidence and prevalence of various types of cancer. Based on end-user, the global market is segmented into pharmaceuticals, biologics, medical devices, and others. On the basis of geography, the global market is segment into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America, followed by Europe, holds the maximum share of the market due to increased research and development expenditure, the presence of major market players, and large number of ongoing clinical trials.
The major players operating in clinical trials services market include Covance, Inc., Charles River Laboratories, Acura Health, Parexel International, Accovion GmbH, ICON PLC, Chiltern International Limited, inVentiv International Pharma Services, Pharmaceutical Product Development LLC, Pharmnet, IQVIA, Quotient Bioresearch, and WuXi PharmaTech, among others.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Clinical Trial Services Market Snapshot

Chapter 4. Global Clinical Trial Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Analysis of Key Vendors in Cancer Clinical Trial/Pipeline

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Major Investment, Partnerships and Collaborations in Cancer Research

Chapter 5. Market Segmentation 1: Phase Estimates & Trend Analysis

5.1. Phase Type & Market Share, 2019 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2018 to 2027 for the following Phase Type:

5.2.1. Phase I

5.2.2. Phase II

5.2.3. Phase III

Chapter 6. Market Segmentation 2: Therapy Area Estimates & Trend Analysis

6.1. Therapy Area & Market Share, 2019 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2018 to 2027 for the following Therapy Area:

6.2.1. Oncology

6.2.2. Neurological disorder

6.2.3. Metabolic disease

6.2.4. Cardiovascular

6.2.5. Rare diseases

6.2.6. Infectious diseases

6.2.7. Others

Chapter 7. Clinical Trial Services Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Clinical Trial Services Market revenue (US$ Million) Estimates and Forecasts by Phase, 2019-2030

7.1.2. North America Clinical Trial Services Market revenue (US$ Million) Estimates and Forecasts by Therapy Area, 2019-2030

7.1.3. North America Clinical Trial Services Market revenue (US$ Million) Estimates and Forecasts by Country, 2019-2030

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Clinical Trial Services Market Revenue (US$ Million) by Phase, 2019-2030

7.2.2. Europe Clinical Trial Services Market Revenue (US$ Million) by Therapy Area, 2019-2030

7.2.3. Europe Clinical Trial Services Market Revenue (US$ Million) by Country, 2019-2030

7.2.3.1. Germany

7.2.3.2. France

7.2.3.3. Italy

7.2.3.4. Spain

7.2.3.5. UK

7.2.3.6. Romania

7.2.3.7. Netherland

7.2.3.8. Belgium

7.2.3.9. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) by Phase, 2019-2030

7.3.2. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) by Therapy Area, 2019-2030

7.3.3. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) by Country, 2019-2030

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Clinical Trial Services Market Revenue (US$ Million) by Phase, (US$ Million)

7.4.2. Latin America Clinical Trial Services Market Revenue (US$ Million) by Country, (US$ Million) 2019-2030

7.4.2.1. Brazil

7.4.2.2. Rest of Latin America

7.5. Middle East & Africa

7.5.1. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) by Phase, (US$ Million)

7.5.2. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) by Country, (US$ Million) 2019-2030

7.5.2.1. GCC Countries

7.5.2.2. Rest of Middle East & Africa

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Covance, Inc

8.2.2. Charles River Laboratories

8.2.3. Alcura Health

8.2.4. Parexel International

8.2.5. Accovion GmbH

8.2.6. ICON PLC

8.2.7. Chiltern International Limited

8.2.8. inVentiv International Pharma Services

8.2.9. Pharmaceutical Product Development LLC

8.2.10. Pharmnet

8.2.11. IQVIA

8.2.12. Syneos Health

8.2.13. Quotient Bioresearch

8.2.14. WuXi PharmaTech

8.2.15. Other Prominent Player

Global Clinical Trial Services Market Segmentation

Global Clinical Trial Services Market Outlook (Revenue, US$ Mn, 2019 – 2030), by Phase

  • Phase I
  • Phase II
  • Phase III

Global Clinical Trial Services Market Outlook (Revenue, US$ Mn, 2019 – 2030), by Therapy Area

  • Oncology
  • Neurological disorder
  • Metabolic disease
  • Cardiovascular
  • Rare diseases
  • Infectious diseases
  • Others

Global Clinical Trial Services Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region

  • Europe
  • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Australia & New Zealand
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients